ABSCINT Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
6
ABSCINT General Information
Description
Developer of an in vivo molecular imaging diagnostics platform designed to improve patient stratification and treatment monitoring. The company offers PET-based molecular imaging diagnostics, including an anti-HER receptor tracer for whole-body assessment of receptor expression and tumor heterogeneity, enabling oncologists and cancer care teams to more accurately stratify patients and monitor treatment response.
Contact Information
Website
www.abscint.com(Operating Subsidiary)
Corporate Office
- Boulevard Patience et Beaujonc 3
- 4000 Liège
- Belgium
Corporate Office
- Boulevard Patience et Beaujonc 3
- 4000 Liège
- Belgium
ABSCINT Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ABSCINT Comparisons
Industry
Financing
Details
ABSCINT Competitors (2)
One of ABSCINT’s 2 competitors is Affibody, a Venture Capital-Backed company based in Solna, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Affibody | Venture Capital-Backed | Solna, Sweden | ||||
| ImaginAb | Venture Capital-Backed | Calabasas, CA |
ABSCINT Patents
ABSCINT Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024366659-A1 | Image guided biopsy of her2 positive lesions | Pending | 26-Oct-2023 | ||
| EP-4798258-A1 | Image guided biopsy of her2 positive lesions | Pending | 26-Oct-2023 | ||
| WO-2025088085-A1 | Image guided biopsy of her2 positive lesions | Inactive | 26-Oct-2023 | ||
| JP-2026538079-A | Image-guided biopsy of her2-positive lesions | Pending | 26-Oct-2023 |
ABSCINT Signals
ABSCINT Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ABSCINT FAQs
-
When was ABSCINT founded?
ABSCINT was founded in 2020.
-
Where is ABSCINT headquartered?
ABSCINT is headquartered in Liège, Belgium.
-
What is the size of ABSCINT?
ABSCINT has 10 total employees.
-
What industry is ABSCINT in?
ABSCINT’s primary industry is Diagnostic Equipment.
-
Is ABSCINT a private or public company?
ABSCINT is a Private company.
-
What is ABSCINT’s current revenue?
The current revenue for ABSCINT is .
-
How much funding has ABSCINT raised over time?
ABSCINT has raised $3.93M.
-
Who are ABSCINT’s investors?
Bruzz - Vlaams-Brusselse Media, Kazoku, Lifetech Brussels, Noshaq, and Qbic Fund are 5 of 10 investors who have invested in ABSCINT.
-
Who are ABSCINT’s competitors?
-
When was ABSCINT acquired?
ABSCINT was acquired on 10-Aug-2026.
-
Who acquired ABSCINT?
ABSCINT was acquired by Curium Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process